Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juan Krauss is active.

Publication


Featured researches published by Juan Krauss.


Journal of the American College of Cardiology | 2009

Prospective Validation of the Prognostic Usefulness of Brain Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Mitral Regurgitation

Rodolfo Pizarro; Oscar Bazzino; Pablo Oberti; Mariano Falconi; Federico Achilli; Aníbal Arias; Juan Krauss; Arturo Cagide

OBJECTIVESnThe purpose of the study was to determine the independent and additive prognostic value of brain natriuretic peptide (BNP) in patients with severe asymptomatic mitral regurgitation and normal left ventricular function.nnnBACKGROUNDnEarly surgery could be advisable in selected patients with chronic severe mitral regurgitation, but there are no criteria to identify candidates who could benefit from this strategy. Assessment of BNP has not been studied in asymptomatic patients with severe mitral regurgitation; hence, its prognostic value remains unclear.nnnMETHODSnWe prospectively evaluated 269 consecutive patients with severe asymptomatic organic mitral regurgitation and left ventricular ejection fraction above 60%. The first 167 consecutive patients served as the derivation cohort, and the following 102 patients served as a validation cohort. The combined end point was the occurrence of either symptoms of congestive heart failure, left ventricular dysfunction, or death at follow-up.nnnRESULTSnThe end point was reached in 35 (21%) patients of the derivation set and in 21 (20.6%) patients of the validation cohort. The receiver-operating characteristics curve yielded an optimal cutoff point of 105 pg/ml of BNP that was able to discriminate patients at higher risk in both cohorts (76% vs. 5.4% and 66% vs. 4.0%, respectively). In both sets, BNP was the strongest independent predictor by multivariate analysis.nnnCONCLUSIONSnAmong patients with severe asymptomatic organic mitral regurgitation, BNP > or =105 pg/ml discriminates a subgroup of patients at higher risk. Because of its incremental prognostic value, BNP assessment should be considered in clinical routine workup for risk stratification.


Revista Espanola De Cardiologia | 2011

Aplicabilidad clínica de la función de Framingham a 30 años. Utilidad en la estratificación del riesgo cardiovascular y en el diagnóstico de placa aterosclerótica carotídea

Walter Masson; Daniel Siniawski; Juan Krauss; Arturo Cagide

INTRODUCTION AND OBJECTIVESnThe traditional Framingham score underestimates cardiovascular risk in certain populations. Extending its time-scale to 30 years and assessing its relationship with the presence of carotid atherosclerotic plaque may improve risk stratification. The objectives were: a) to determine the percentage of patients previously classified with the traditional score who were reclassified when using Framingham 30-year risk score; b) to analyze the prevalence of carotid atherosclerotic plaque; and c) to determine the diagnostic potential of the 30-year score to detect carotid plaque.nnnMETHODSnA carotid Doppler ultrasound study was performed and the Framingham 10-year risk score and 30-year score (based on lipids and body mass index) for hard cardiovascular events were calculated in a population of primary prevention patients. Prevalence of carotid plaque was determined. Receiver operating characteristic analysis was conducted.nnnRESULTSnIn total, 305 subjects were included (age 48 [11] years, 52% men). The 30-year scores based on lipids and on body mass index reclassified 70% and 63% of the population, respectively. Prevalence of carotid plaque was 28.5% and associated gradually with risk category. The area under the curve and optimal cutoff points of the 30-year score to detect carotid plaque were 0.862 and 26% (based on lipids) and 0.845 and 22% (based on body mass index), respectively.nnnCONCLUSIONSnThe 30-year score reclassified a large number of patients and discriminated between those with or without evidence of carotid plaque.


Journal of Cardiovascular Magnetic Resonance | 2007

Cardiac Fibroelastoma: Cardiovascular Magnetic Resonance Characteristics

Diego Pérez de Arenaza; Marcelo Pietrani; James C. Moon; Hernán García Rivello; Nicolás Cóccaro; Juan Krauss; Arturo Cagide; Ricardo García Mónaco

Diego Perez de Arenaza,1 Marcelo Pietrani,2 James C. Moon, 3 Hernan Garcia Rivello,4 Nicolas Coccaro,2 Juan Krauss,1 Arturo Cagide,1 Ricardo Garcia Monaco2 Cardiology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina1 Radiology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina2 The Heart Hospital, London, UK 3 Pathology Departments, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina4


American Heart Journal | 2006

Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance

Juan Krauss; Rodolfo Pizarro; Pablo Oberti; Mariano Falconi; Arturo Cagide


Revista Espanola De Cardiologia | 2011

Clinical Applicability of the Framingham 30-Year Risk Score. Usefulness in Cardiovascular Risk Stratification and the Diagnosis of Carotid Atherosclerotic Plaque

Walter Masson; Daniel Siniawski; Juan Krauss; Arturo Cagide


Revista Argentina de Cardiología | 2010

Niveles plasmáticos de apolipoproteínas en una población saludable de la Argentina: implicaciones en prevención cardiovascular

Daniel Siniawski; Walter Masson; Ignacio Bluro; Patricia Sorroche; Walter Scordo; Juan Krauss; Arturo Cagide


Revista Argentina de Cardiología | 2011

Función de Framingham a 30 años basada en el índice de masa corporal. Utilidad en la estratificación del riesgo cardiovascular y en el diagnóstico de placa aterosclerótica carotídea

Walter Masson; Daniel Siniawski; Juan Krauss; Arturo Cagide


Revista Argentina de Cardiología | 2008

Risk Stratification in Severe and Asymptomatic Mitral Valve Insufficiency: How Could Patients with Adverse Outcomes Be Identified?

Mariano L. Falconimtsac; Pablo F. Obertimtsac; Aníbal Arias; Federico Achilli; Fredes Tewel; Diego Funes; Juan Krauss; Arturo M. Cagidemtsac; Mariano L. Falconi


Medicina Clinica | 2017

Mortalidad en pacientes con psoriasis. Análisis de una cohorte retrospectiva

Walter Masson; Emiliano Rossi; María Laura Galimberti; Juan Krauss; José Luis Navarro Estrada; Ricardo Galimberti; Arturo Cagide


Revista Argentina de Cardiología | 2011

Análisis de costo-efectividad de estrategias alternativas en el manejo de pacientes con accidente cerebrovascular criptogénico y foramen oval permeable

Aníbal Arias; Walter Masson; Pablo Oberti; Mariano L. Falconi; Rodolfo Pizarro; Juan Krauss; Arturo Cagide

Collaboration


Dive into the Juan Krauss's collaboration.

Top Co-Authors

Avatar

Arturo Cagide

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Walter Masson

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Daniel Siniawski

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Aníbal Arias

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Pablo Oberti

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Rodolfo Pizarro

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Federico Achilli

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

José Luis Navarro Estrada

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Mariano Falconi

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Emiliano Rossi

Hospital Italiano de Buenos Aires

View shared research outputs
Researchain Logo
Decentralizing Knowledge